Median PFS according to KRAS and TP53
| KRAS and TP53 molecular profile | N | Events | PFS median | 0.95LCL | 0.95UCL |
|---|---|---|---|---|---|
| KRAS-wt; TP53-wt | 20 | 20 | 3.3 | 1.8 | 10.9 |
| KRAS-m; TP53-wt | 31 | 27 | 3.7 | 2.3 | 14.0 |
| KRAS-wt; TP53-m | 33 | 25 | 4.1 | 2.2 | 14.1 |
| KRAS-m; TP53-m | 23 | 21 | 3.0 | 1.9 | 17.2 |
KRAS: Kirsten rat sarcoma viral oncogene homolog; TP53: tumor protein p53; N: number of patients; KRAS-wt: KRAS wild type; KRAS-m: KRAS mutated; TP53-wt: TP53 wild type; TP53-m: TP53 mutated; PFS: progression free survival; LCL: lower control limit; UCL: upper control limit